Business / Finance

RSS

RQM+ Launches Clinical Trial Services

RQM+ today announced the launch of its clinical trial services division to complete its full complement of MedTech contract research organization (CRO) services.

From RQM+ 4 Jan 2023

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Berkeley Lights (Nasdaq: BLI) and IsoPlexis (Nasdaq: ISO) today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

From Bruker Cellular Analysis 3 Jan 2023

Fujifilm announces asset purchase agreement with Inspirata, Inc. to acquire the company’s digital pathology business

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspirata's Dynamyx® digital pathology technology, employees and customers will become part of Fujifilm.

From FUJIFILM Corporation 20 Dec 2022

CN Bio appoints Dr Paul Brooks as Chief Executive Officer

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks, formerly the Company’s Chief Business Officer, to the position of CEO with immediate effect. Former CEO, Dr David Hughes, will continue to work with the company in a consultative role within the Company’s Scientific Advisory Board.

From CN-Bio 19 Dec 2022

Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal

Global Access Diagnostics (GADx) today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant diseases affecting calves

From Global Access Diagnostics 16 Dec 2022

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

PhoreMost Ltd. and ThinkCyte K.K today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).

From PhoreMost 16 Dec 2022

INTEGRA Biosciences furthers scientific education with festive donation

INTEGRA Biosciences is proud to be supporting the Smithsonian Science Education Center (SSEC) with a $20,000 donation this festive season.

From INTEGRA Biosciences 16 Dec 2022

Sphere Fluidics appoints Richard Hammond as Chief Technical Officer

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Richard Hammond as Chief Technical Officer.

From Sphere Fluidics 16 Dec 2022

Metrion Biosciences and The KCNC1 Foundation Collaborate on New Ion Channel Modulators

...

From Metrion Biosciences Limited 7 Dec 2022

Envomed appoints Hagai Yehidi as new CEO

Envomed, the brand behind the Envomed80 on-site medical waste treatment solution, has appointed Hagai Yehidi as its new CEO.

From Envomed 29 Nov 2022

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they had entered into a formal collaboration.

From Sartorius 23 Nov 2022

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.

From The Native Antigen Company 23 Nov 2022

Over 440 SCI articles published! BGI’s cancer genetics and cell research fuels innovation

BGI has currently published over 440 SCI (Science Citation Index) papers in the field of cancer research, with a cumulative impact factor of over 4,000 points.

From BGI Genomics 23 Nov 2022

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.

From FUJIFILM Corporation 22 Nov 2022

New Vision Display announces a new driver for its ZBD displays

...

From New Vision Display 22 Nov 2022

FUJIFILM Healthcare Europe partners with The Royal College of Surgeons of Edinburgh

FUJIFILM Healthcare Europe, a leading provider of medical imaging solutions, has become an organizational partner of the Faculty of Remote, Rural and Humanitarian Healthcare (FRRHH), part of The Royal College of Surgeons of Edinburgh.

From FUJIFILM Corporation 22 Nov 2022

Hungary sees 116% growth in non-invasive prenatal testing

...

From BGI Genomics 21 Nov 2022

Grenova wins 2022 Lab Innovations Sustainable Product of the Year

Grenova, the laboratory industry’s only patented technology for washing and reusing plastic consumables, announced today it received the 2022 Sustainable Product of the Year Award at the Lab Innovations Conference in Birmingham, United Kingdom. In addition, Grenova was recently shortlisted by SelectScience® as a finalist for its award honoring impact on sustainability in life sciences and by SAMPS for Grenova’s talented employees committed to sustainability.

From Grenova 10 Nov 2022

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

...

From MGI 7 Nov 2022

Curia celebrates ground-breaking ceremony in Albuquerque

Curia today hosted a ground-breaking ceremony to mark the beginning of construction of its expanded campus in Albuquerque, New Mexico.

From Curia 31 Oct 2022